Litcius/Paper detail

715MO Safety and efficacy of sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated advanced endometrial carcinoma (EC) and ovarian cancer (OC) from a phase II study

Dadong Wang, K. Wang, Rui An, Guohua Yu, Kai Zhang, Dadong Wang, Kuirong Jiang, Y.-T. Gao, Yangyang Cheng, Y Liu, Hu Qiu, Lingling Wang, Tianshu Liu, B. Akala, Elliot Chartash, Y. Li, Xing Li, Xing Jin, Jie Ge, J. Li

2024Annals of Oncology15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEndometrial cancerGynecologyCarcinomaOncologyCancerOvarian cancerInternal medicineOvarian carcinomaPhases of clinical researchUrologyChemotherapyOvarian cancer diagnosis and treatmentEndometrial and Cervical Cancer TreatmentsUterine Myomas and Treatments
715MO Safety and efficacy of sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated advanced endometrial carcinoma (EC) and ovarian cancer (OC) from a phase II study | Litcius